These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9519350)

  • 21. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carvedilol for children and adolescents with heart failure: a randomized controlled trial.
    Shaddy RE; Boucek MM; Hsu DT; Boucek RJ; Canter CE; Mahony L; Ross RD; Pahl E; Blume ED; Dodd DA; Rosenthal DN; Burr J; LaSalle B; Holubkov R; Lukas MA; Tani LY;
    JAMA; 2007 Sep; 298(10):1171-9. PubMed ID: 17848651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.
    Colucci WS; Packer M; Bristow MR; Gilbert EM; Cohn JN; Fowler MB; Krueger SK; Hershberger R; Uretsky BF; Bowers JA; Sackner-Bernstein JD; Young ST; Holcslaw TL; Lukas MA
    Circulation; 1996 Dec; 94(11):2800-6. PubMed ID: 8941105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.
    Packer M; Colucci WS; Sackner-Bernstein JD; Liang CS; Goldscher DA; Freeman I; Kukin ML; Kinhal V; Udelson JE; Klapholz M; Gottlieb SS; Pearle D; Cody RJ; Gregory JJ; Kantrowitz NE; LeJemtel TH; Young ST; Lukas MA; Shusterman NH
    Circulation; 1996 Dec; 94(11):2793-9. PubMed ID: 8941104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.
    Bellenger NG; Rajappan K; Rahman SL; Lahiri A; Raval U; Webster J; Murray GD; Coats AJ; Cleland JG; Pennell DJ;
    Heart; 2004 Jul; 90(7):760-4. PubMed ID: 15201244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
    Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
    Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction.
    Takeda Y; Fukutomi T; Suzuki S; Yamamoto K; Ogata M; Kondo H; Sugiura M; Shigeyama J; Itoh M
    Am J Cardiol; 2004 Aug; 94(4):448-53. PubMed ID: 15325927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study.
    Arnold RH; Kotlyar E; Hayward C; Keogh AM; Macdonald PS
    Heart; 2003 Mar; 89(3):293-8. PubMed ID: 12591834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure.
    Greenberg BH; Mehra M; Teerlink JR; Ordronneau P; McCollum D; Gilbert EM
    Am J Cardiol; 2006 Oct; 98(7A):53L-59L. PubMed ID: 17023233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-blockers in heart failure: potential of carvedilol.
    Fowler MB
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S62-7. PubMed ID: 8098065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of dilated cardiomyopathy with carvedilol in children.
    Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
    Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second- and third-generation beta-blocking drugs in chronic heart failure.
    Bristow MR; Abraham WT; Yoshikawa T; White M; Hattler BG; Crisman TS; Lowes BD; Robertson AD; Larrabee P; Gilbert EM
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():291-6. PubMed ID: 9211023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term treatment with the beta-blocker carvedilol restores autonomic tone and responsiveness in patients with moderate heart failure.
    Malfatto G; Facchini M; Branzi G; Riva B; Sala L; Perego GB
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):125-31. PubMed ID: 12827037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effectiveness of carvedilol in heart failure].
    Kárpáti K; Brodszky V; Farsang C; Jermendy G; Vándorfi G; Zámolyi K; Gulácsi L
    Orv Hetil; 2006 Oct; 147(40):1931-7. PubMed ID: 17111685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure EvaluatioN trial (CARMEN)--rationale and design.
    Remme WJ;
    Cardiovasc Drugs Ther; 2001 Jan; 15(1):69-77. PubMed ID: 11504166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of sodium current in chronic heart failure: effect of long-term therapy with carvedilol.
    Maltsev VA; Sabbab HN; Undrovinas AI
    Cell Mol Life Sci; 2002 Sep; 59(9):1561-8. PubMed ID: 12440776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of carvedilol in the treatment of heart failure.
    Coats A
    Hosp Med; 2003 May; 64(5):288-91. PubMed ID: 12789738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.